speb/financial-data huggingface dataset:
Stock screener scorecard for 1064.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 46116988 (Nano Cap (< $50M))
Debt to equity: 0.1308
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1064.HK (annual, report date 2025-12-31)
Altman Z-score: 0.23405368116138328 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.214502418546088%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.29218583259435166%
Free cash flow margin: 62.43249288978365%
Revenue growth: 9.440937131566884%
Rule of 40 score: 71.87343002135054
Market cap: 46116988 (Nano Cap (< $50M))
P/E ratio: 4.144123576985289
Debt to equity: 0.1308
Free cash flow (dilution adjusted): 2511182.5192802055
Operating income: 499742.9305912596
Net income: 1668766.0668380463
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 1204.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 800000000 (Small Cap ($300M-$2B))
P/E ratio: 12.853470437017993
Debt to equity: 0.2657
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 1418.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 271250304 (Micro Cap ($50M-$300M))
P/E ratio: 0.9854327335047129
Debt to equity: 0.9823000000000001
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1418.HK (annual, report date 2025-12-31)
Altman Z-score: 2.1036777283705033 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 24.794466538455193%
Capitalized R&D asset: 22512111.306817397
ROCI (R&D adjusted): 8.207307164884359%
Rosenberg metric: 0.5961443855352629
Free cash flow margin: 1.6688579285176672%
Revenue growth: 14.5061444828171%
Rule of 40 score: 16.175002411334766
Market cap: 271250304 (Micro Cap ($50M-$300M))
P/E ratio: 0.9854327335047129
Debt to equity: 0.9823000000000001
Free cash flow (dilution adjusted): 10074678.663239075
Operating income: 15413239.074550128
Net income: 10905655.526992287
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1721.HK (quarterly, report date 2025-06-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 140000000 (Micro Cap ($50M-$300M))
Debt to equity: 0.5245000000000001
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 190A.T (quarterly, report date 2026-02-28)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5791662592 (Mid Cap ($2B-$10B))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2122.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8781286400 (Mid Cap ($2B-$10B))
P/E ratio: 0.1205006699959484
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2337.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 483107584 (Small Cap ($300M-$2B))
Debt to equity: 1.7744
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3597.T (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 25879255040 (Large Cap ($10B-$200B))
P/E ratio: 0.13657740855103948
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3690.HK (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 535098589184 (Mega Cap (>= $200B))
Debt to equity: 0.7526
Long score: 1 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 4875.T (quarterly, report date 2026-03-31)
Altman Z-score: 1920.4685761768967 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -10.368391338839047%
Capitalized R&D asset: 2818986.48
ROCI (R&D adjusted): -7.156265768434443%
Rosenberg metric: 0.007858527075278975
Free cash flow margin: -2079.7496042442135%
Revenue growth: 23.227383863080682%
Rule of 40 score: -2056.5222203811327
Market cap: 10631789568 (Large Cap ($10B-$200B))
Debt to equity: 0.0042
Free cash flow (dilution adjusted): -3888799
Operating income: -2835806
Net income: -2586258
Long score: 5 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 6165.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 13630379008 (Large Cap ($10B-$200B))
P/E ratio: 0.09503685974274209
Debt to equity: 0.1336
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6660.HK (annual, report date 2025-12-31)
Altman Z-score: 0.19268284569639696 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -40.196359973333045%
Capitalized R&D asset: 90190601.89584418
ROCI (R&D adjusted): -9.537956464113524%
Rosenberg metric: -0.4426117341402943
Free cash flow margin: -14.703437413408391%
Revenue growth: -5.400693501891054%
Rule of 40 score: -20.104130915299443
Market cap: 1827578240 (Small Cap ($300M-$2B))
Debt to equity: 0.5981000000000001
Free cash flow (dilution adjusted): -24484857.14285714
Operating income: -27431285.714285713
Net income: -96494285.71428572
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 6660.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1827578240 (Small Cap ($300M-$2B))
Debt to equity: 0.5981000000000001
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7150.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3995638784 (Mid Cap ($2B-$10B))
P/E ratio: 0.1866608695448086
Debt to equity: 1.4735736221108744
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7150.T (annual, report date 2026-03-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 8.102866779089377%
Capitalized R&D asset: 0
Free cash flow margin: -46.973821989528794%
Revenue growth: 2.9645603908446687%
Rule of 40 score: -44.00926159868413
Market cap: 3995638784 (Mid Cap ($2B-$10B))
P/E ratio: 0.1866608695448086
Debt to equity: 1.4735736221108744
Free cash flow (dilution adjusted): -28065565.565565564
Net income: 2321071.071071071
Long score: 0 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 7678.T (quarterly, report date 2026-04-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 33220872192 (Large Cap ($10B-$200B))
P/E ratio: 0.5551572070996675
Debt to equity: 0.028999999999999998
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8078.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 332841517056 (Mega Cap (>= $200B))
P/E ratio: 0.05031572224736389
Debt to equity: 0.8127
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9252.T (quarterly, report date 2026-02-28)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 10446711808 (Large Cap ($10B-$200B))
P/E ratio: 0.07307054466941702
Debt to equity: 0.7465
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9636.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 14833567744 (Large Cap ($10B-$200B))
P/E ratio: 2.634961439588689
Debt to equity: 0.0014000000000000002
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9742.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 44955664384 (Large Cap ($10B-$200B))
Debt to equity: 0.1014
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 9742.T (annual, report date 2026-03-31)
Altman Z-score: 3.5537398324827727 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -0.8661745445886415%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.527185312625203%
Free cash flow margin: 2.9986890976622242%
Revenue growth: -15.502275936661958%
Rule of 40 score: -12.503586838999734
Market cap: 44955664384 (Large Cap ($10B-$200B))
Debt to equity: 0.1014
Free cash flow (dilution adjusted): 6869369.369369369
Operating income: -4054054.054054054
Net income: -11530280.28028028
Long score: 7 | Short score: 9
Recommendation: Neutral
Stock screener scorecard for 9759.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 202485301248 (Mega Cap (>= $200B))
P/E ratio: 0.10055287238443653
Debt to equity: 0
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 9886.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1003939456 (Small Cap ($300M-$2B))
Debt to equity: 0.16829999999999998
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 9886.HK (annual, report date 2025-12-31)
Altman Z-score: -0.5207311475454028 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 16399360.359847076
ROCI (R&D adjusted): -2.139565398219092%
Rosenberg metric: 4.233396683235702
Free cash flow margin: 1.2143761877843444%
Revenue growth: 9.170443439643918%
Rule of 40 score: 10.384819627428262
Market cap: 1003939456 (Small Cap ($300M-$2B))
Debt to equity: 0.16829999999999998
Free cash flow (dilution adjusted): 8479428.57142857
Operating income: -5487142.857142857
Net income: -7002571.428571428
Long score: 6 | Short score: 8
Recommendation: Neutral
Stock screener scorecard for AAMI (quarterly, report date 2026-03-31)
Altman Z-score: 3.3512325353800794 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 42.13286713286713%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.674561159097241%
Free cash flow margin: -29.221556886227546%
Revenue growth: -3.0197444831591174%
Rule of 40 score: -32.24130136938666
Market cap: 2881672448 (Mid Cap ($2B-$10B))
P/E ratio: 23.127659574468083
Debt to equity: 3.4657999999999998
Free cash flow (dilution adjusted): -48800000
Operating income: 41900000
Net income: 24400000
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for ABMINTLLTD.NS (quarterly, report date 2025-09-30)
Altman Z-score: 1.880620451363908 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.053282777888645%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -3.4973566490443266%
Revenue growth: -42.92269290073833%
Rule of 40 score: -42.92269290073833
Market cap: 385916160 (Small Cap ($300M-$2B))
Debt to equity: 0.7283
Operating income: -52356.257046223225
Net income: -45975.19729425028
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for ACNT (quarterly, report date 2026-03-31)
Altman Z-score: 5.390324411769355 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.804244535951853%
Capitalized R&D asset: 63000
ROCI (R&D adjusted): -2.479654930624907%
Free cash flow margin: -30.93999484934329%
Revenue growth: 3.496988112372728%
Rule of 40 score: -27.44300673697056
Market cap: 136703008 (Micro Cap ($50M-$300M))
P/E ratio: 101.94800139830508
Debt to equity: 0.1617
Free cash flow (dilution adjusted): -6007000
Operating income: -2376000
Net income: -1980000
Long score: 4 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for AHRT (quarterly, report date 2026-03-31)
Altman Z-score: 0.3474190974387898 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -0.9917105647492522%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.5465102616961229%
Free cash flow margin: 21.258864231511744%
Rule of 40 score: 21.258864231511744
Market cap: 683819456 (Small Cap ($300M-$2B))
Debt to equity: 1.791
Free cash flow (dilution adjusted): 11122000
Operating income: 11768000
Net income: -23164000
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for ARCM.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 15987316 (Nano Cap (< $50M))
Debt to equity: 0.060599999999999994
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ARCM.L (annual, report date 2025-12-31)
Altman Z-score: -16.67462351461322 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -142.89646411179336%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -59.36794582392777%
Rule of 40 score: 0
Market cap: 15987316 (Nano Cap (< $50M))
Debt to equity: 0.060599999999999994
Free cash flow (dilution adjusted): -1883783.783783784
Operating income: -2132432.4324324327
Net income: -9108108.108108109
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for ARF.AX (annual, report date 2025-06-30)
Altman Z-score: 2.391426887926702 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 6.67155149123597%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.445416636721876%
Free cash flow margin: 68.23159751571056%
Revenue growth: 9.448197831307954%
Rule of 40 score: 77.67979534701851
Market cap: 1293100288 (Small Cap ($300M-$2B))
P/E ratio: 6.037151702786377
Debt to equity: 0.3233
Free cash flow (dilution adjusted): 48539869.28104575
Operating income: 64875163.39869281
Net income: 53262091.50326797
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ARF.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1293100288 (Small Cap ($300M-$2B))
P/E ratio: 6.037151702786377
Debt to equity: 0.3233
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ASPN (quarterly, report date 2026-03-31)
Altman Z-score: -2.0683226617780632 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -9.216054558143675%
Capitalized R&D asset: 5419670
ROCI (R&D adjusted): -6.203735060585169%
Rosenberg metric: 9.73345259391771
Free cash flow margin: 81.59645232815964%
Revenue growth: -8.357725150584194%
Rule of 40 score: 73.23872717757544
Market cap: 387037728 (Small Cap ($300M-$2B))
Debt to equity: 0.6034
Free cash flow (dilution adjusted): 30912000
Operating income: -20407000
Net income: -23691000
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for BMY.L (quarterly, report date 2026-02-28)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 490717760 (Small Cap ($300M-$2B))
P/E ratio: 0.18959868959868958
Debt to equity: 0.138
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CETX (quarterly, report date 2026-03-31)
Altman Z-score: -1.892230795612111 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.725266441010952%
Capitalized R&D asset: 981358.44
ROCI (R&D adjusted): -4.367238653254751%
Rosenberg metric: 2.4436626880851953
Free cash flow margin: -25.312203666533108%
Revenue growth: 11.950776874009309%
Rule of 40 score: -13.3614267925238
Market cap: 4647081 (Nano Cap (< $50M))
P/E ratio: 0.010811278325549213
Debt to equity: 0.6564
Free cash flow (dilution adjusted): -4571730
Operating income: -2172037
Net income: 907048
Long score: 3 | Short score: 11
Recommendation: Short
Stock screener scorecard for CEV.MC (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 231635120 (Micro Cap ($50M-$300M))
P/E ratio: 7.2610294117647065
Debt to equity: 0.185
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CEV.MC (annual, report date 2025-12-31)
Altman Z-score: 1.1089462135593389 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 6.073853811772054%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.383311270582224%
Free cash flow margin: 11.610451002938547%
Revenue growth: -6.008443568815074%
Rule of 40 score: 5.602007434123473
Market cap: 231635120 (Micro Cap ($50M-$300M))
P/E ratio: 7.2610294117647065
Debt to equity: 0.185
Free cash flow (dilution adjusted): 4276470.588235294
Operating income: 38178823.52941176
Net income: 36141176.47058824
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CGEO.L (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1286010368 (Small Cap ($300M-$2B))
P/E ratio: 0.037373362984927105
Net income: 39361842.10526316
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CYL.V (annual, report date 2022-03-31)
Altman Z-score: -9.503848164374746 (Distress Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -2826.0885092280446%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2271.866981618602%
Rule of 40 score: 0
Market cap: 3086429 (Nano Cap (< $50M))
Debt to equity: 14.618143248957155
Free cash flow (dilution adjusted): -2840312
Operating income: -2854573.6
Net income: -3198105.6
Long score: 0 | Short score: 13
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for D (quarterly, report date 2026-03-31)
Altman Z-score: 0.5243468607309605 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -6.119020956646937%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.2681768905835296%
Free cash flow margin: -42.054606167747004%
Revenue growth: 20.926365795724465%
Rule of 40 score: -21.12824037202254
Market cap: 62533337088 (Large Cap ($10B-$200B))
P/E ratio: 18.05604719764012
Debt to equity: 1.5490000000000002
Free cash flow (dilution adjusted): -2141000000
Operating income: 1357000000
Net income: 785000000
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for DTIL.NS (annual, report date 2026-03-31)
Altman Z-score: 0.5126685806560328 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -3.451677590866495%
Free cash flow margin: -3.1891714067408095%
Revenue growth: -6.411034799531036%
Rule of 40 score: -9.600206206271846
Market cap: 1390763008 (Small Cap ($300M-$2B))
Debt to equity: 0.4779
Free cash flow (dilution adjusted): -1592422.6367104705
Operating income: -2784739.2963119964
Net income: -265377.27850784233
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for DTIL.NS (quarterly, report date 2026-03-31)
Altman Z-score: -0.05597207783802202 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -5.1402881297482415%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -8.297632317941899%
Revenue growth: -70.37397335807528%
Rule of 40 score: -70.37397335807528
Market cap: 1390763008 (Small Cap ($300M-$2B))
Debt to equity: 0.4779
Operating income: -6694351.42009326
Net income: -3274618.4824078
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for EKF.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 110503096 (Micro Cap ($50M-$300M))
Debt to equity: 0.0197
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for EPY.AX (annual, report date 2025-06-30)
Altman Z-score: 0.2652932593641653 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.906651798921333%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -5.103364363686451%
Free cash flow margin: 42.05540404765322%
Revenue growth: -6.313201945006244%
Rule of 40 score: 35.74220210264698
Market cap: 28339922 (Nano Cap (< $50M))
P/E ratio: 12.418300653594772
Debt to equity: 3.5008999999999997
Free cash flow (dilution adjusted): 5745098.039215686
Operating income: -5811764.705882353
Net income: 1874509.8039215687
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for EPY.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 28339922 (Nano Cap (< $50M))
P/E ratio: 12.418300653594772
Debt to equity: 3.5008999999999997
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for FPH.AX (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 86870285.71428572
Rule of 40 score: 0
Market cap: 19192604672 (Large Cap ($10B-$200B))
P/E ratio: 31.537982565379828
Debt to equity: 0.0691
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for FTRC.V (quarterly, report date 2026-03-31)
Altman Z-score: -5.772345586687885 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -132.0684291306332%
Free cash flow margin: -130.54424058627154%
Revenue growth: -19.703288833320478%
Rule of 40 score: -150.247529419592
Market cap: 24695934 (Nano Cap (< $50M))
Debt to equity: -0.6181113957757559
Free cash flow (dilution adjusted): -1520553.9568345326
Operating income: -1927725.8992805756
Net income: -1900732.3741007196
Long score: 1 | Short score: 15
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for GGAL (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.7309269281896937%
Capitalized R&D asset: 0
Revenue growth: 0.12817879356626113%
Rule of 40 score: 0.12817879356626113
Market cap: 8354054656 (Mid Cap ($2B-$10B))
P/E ratio: 127.30555555555556
Debt to equity: 0.3781380376819498
Net income: 47565170.74915072
Long score: 2 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for GHV2.L (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 168395776 (Micro Cap ($50M-$300M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for HAN.V (quarterly, report date 2026-02-28)
Altman Z-score: 350.0297001020298 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -8.196526313286283%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.3266946806868776%
Rule of 40 score: 0
Market cap: 117302064 (Micro Cap ($50M-$300M))
Debt to equity: 0
Free cash flow (dilution adjusted): -1424940.8759124088
Operating income: -204426.27737226276
Net income: -185100
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for HGEA.DE (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8320000 (Nano Cap (< $50M))
Debt to equity: 1.1155
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for HGEA.DE (annual, report date 2025-12-31)
Altman Z-score: -0.8823887439641844 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -19.68494066521812%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -61.69412779001821%
Free cash flow margin: -3.0113265083859724%
Revenue growth: 8.349707176076013%
Rule of 40 score: 5.338380667690041
Market cap: 8320000 (Nano Cap (< $50M))
Debt to equity: 1.1155
Free cash flow (dilution adjusted): -3252941.1764705884
Operating income: -30307058.82352941
Net income: -32757647.05882353
Long score: 0 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for IMVT (annual, report date 2026-03-31)
Altman Z-score: 43.15979353376044 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -59.25518888284197%
Capitalized R&D asset: 768740630
ROCI (R&D adjusted): -25.888806460810372%
Rule of 40 score: 0
Market cap: 8091224064 (Mid Cap ($2B-$10B))
Debt to equity: 0.0001
Free cash flow (dilution adjusted): -463042000
Operating income: -532902000
Net income: -505606000
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for IMVT (quarterly, report date 2026-03-31)
Altman Z-score: 44.44718159704896 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -17.331619344305366%
Capitalized R&D asset: 246268250
ROCI (R&D adjusted): -12.354042897326268%
Rule of 40 score: 0
Market cap: 8091224064 (Mid Cap ($2B-$10B))
Debt to equity: 0.0001
Free cash flow (dilution adjusted): -106208000
Operating income: -159554000
Net income: -147856000
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for INDOSTAR.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.484974248216223 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -12.009857486283487%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.9344771903617245%
Revenue growth: -4.271394695144982%
Rule of 40 score: -4.271394695144982
Market cap: 42094809088 (Large Cap ($10B-$200B))
P/E ratio: 0.22219807351050005
Debt to equity: 1.4479
Operating income: 9413946.587537091
Net income: -44926875.79482832
Long score: 0 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for INDOSTAR.NS (annual, report date 2026-03-31)
Altman Z-score: 1.6430780068420217 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.640322524988785%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.4779477900450777%
Free cash flow margin: -74.4723632841166%
Revenue growth: -6.162284828825435%
Rule of 40 score: -80.63464811294203
Market cap: 42094809088 (Large Cap ($10B-$200B))
P/E ratio: 0.22219807351050005
Debt to equity: 1.4479
Free cash flow (dilution adjusted): -107547689.699025
Operating income: 24962908.011869438
Net income: 14884484.95125053
Long score: 1 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for ION.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 815122.4466666668
Rule of 40 score: 0
Market cap: 51845776 (Micro Cap ($50M-$300M))
Debt to equity: 0.16210000000000002
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for JHG (quarterly, report date 2026-03-31)
Altman Z-score: 2.559982660013925 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 10.93363757368321%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.6402885986261322%
Free cash flow margin: 30.695652173913047%
Revenue growth: -41.18514354695283%
Rule of 40 score: -10.489491373039783
Market cap: 8004228608 (Mid Cap ($2B-$10B))
P/E ratio: 10.172277227722772
Debt to equity: 0.0691
Free cash flow (dilution adjusted): 278684210.5263158
Operating income: 149868421.0526316
Net income: 140526315.78947368
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for JJJJ.V (quarterly, report date 2026-01-31)
Altman Z-score: 49.66931488014987 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -6.613830831813719%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -6.613830831813719%
Rule of 40 score: 0
Market cap: 2847800 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -19099.25925925926
Operating income: -35624.444444444445
Net income: -35624.444444444445
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for KNTK (quarterly, report date 2026-03-31)
Altman Z-score: 0.8752965429068501 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.05867342980500706%
Free cash flow margin: 17.219544558705877%
Revenue growth: -4.74955798884343%
Rule of 40 score: 12.469986569862447
Market cap: 8429875712 (Mid Cap ($2B-$10B))
P/E ratio: 18.96414342629482
Debt to equity: 1.3685
Free cash flow (dilution adjusted): 70596000
Operating income: -3857000
Net income: -4849000
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for LICHSGFIN.NS (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.6810570418031445%
Capitalized R&D asset: 0
Revenue growth: -0.11798972891412773%
Rule of 40 score: -0.11798972891412773
Market cap: 296456454144 (Mega Cap (>= $200B))
P/E ratio: 0.05129843406001402
Debt to equity: 6.4252
Net income: 158184612.12378126
Long score: 0 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for LICHSGFIN.NS (annual, report date 2026-03-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.708655848939355%
Capitalized R&D asset: 0
Free cash flow margin: -95.98625924567207%
Revenue growth: -4.150626017171224%
Rule of 40 score: -100.1368852628433
Market cap: 296456454144 (Mega Cap (>= $200B))
P/E ratio: 0.05129843406001402
Debt to equity: 6.4252
Free cash flow (dilution adjusted): -906725307.3336159
Net income: 593921153.0309453
Long score: 1 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for LMS.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 13763622 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MCB.TO (quarterly, report date 2026-03-31)
Altman Z-score: 1.7890817045514018 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.4758615902543997%
Capitalized R&D asset: 1751095.7307146983
ROCI (R&D adjusted): -3.6639715224819347%
Rosenberg metric: -5.994381453979483
Free cash flow margin: -8.05383465071566%
Revenue growth: -63.89099567962441%
Rule of 40 score: -71.94483033034007
Market cap: 59182268 (Micro Cap ($50M-$300M))
P/E ratio: 9.872102318145485
Debt to equity: 0.1175
Free cash flow (dilution adjusted): -542446.0431654677
Operating income: -1829496.402877698
Net income: -2272661.8705035974
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for MCM.AX (annual, report date 2024-06-30)
Altman Z-score: -8.417076686152612 (Distress Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -16.904996388943605%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -19.893070952814192%
Free cash flow margin: -20.520932769671347%
Revenue growth: -17.611032984367213%
Rule of 40 score: -38.13196575403856
Market cap: 232354432 (Micro Cap ($50M-$300M))
Debt to equity: 0.1333
Free cash flow (dilution adjusted): -5016000
Operating income: -11807333.333333334
Net income: -9546000
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for MDNA.TO (quarterly, report date 2026-03-31)
Altman Z-score: -21.25347129225875 (Distress Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -173.0595482546201%
Capitalized R&D asset: 6202200.073517828
ROCI (R&D adjusted): -47.979834114303124%
Rule of 40 score: 0
Market cap: 32305070 (Nano Cap (< $50M))
Debt to equity: 0.048
Free cash flow (dilution adjusted): -3507194.244604317
Operating income: -4188489.2086330936
Net income: -3046043.165467626
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for MDNA.TO (annual, report date 2026-03-31)
Altman Z-score: -27.73129244201035 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -752.9363449691991%
Capitalized R&D asset: 21554231.12139659
ROCI (R&D adjusted): -59.326326006414696%
Rule of 40 score: 0
Market cap: 32305070 (Nano Cap (< $50M))
Debt to equity: 0.048
Free cash flow (dilution adjusted): -14037410.071942447
Operating income: -16127338.129496405
Net income: -13243884.892086333
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for MENE.V (quarterly, report date 2026-03-31)
Altman Z-score: 9.277929120577223 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 6.272940849859304%
Capitalized R&D asset: 29818.597122302162
ROCI (R&D adjusted): 5.263602479012938%
Free cash flow margin: 28.704317415690596%
Rule of 40 score: 28.704317415690596
Market cap: 46936860 (Nano Cap (< $50M))
P/E ratio: 34.68442951450658
Debt to equity: 0.026699999999999998
Free cash flow (dilution adjusted): 1298900.7194244605
Operating income: 792736.690647482
Net income: 839041.7266187051
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for MICC.L (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8234893312 (Mid Cap ($2B-$10B))
P/E ratio: 0.38826631509558335
Debt to equity: 5.3965
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for MLOCT.PA (annual, report date 2024-12-31)
Altman Z-score: -19.28960885231475 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Revenue growth: -78.61819156914383%
Rule of 40 score: -78.61819156914383
Market cap: 20213224 (Nano Cap (< $50M))
Debt to equity: -0.8336364481749845
Operating income: -560976.0416666667
Net income: -686568.75
Long score: 1 | Short score: 11
Recommendation: Short
Stock screener scorecard for MUFIN.NS (annual, report date 2026-03-31)
Altman Z-score: 2.215302593993432 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.690992561963336%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.8230700285616261%
Free cash flow margin: -336.7538269730301%
Revenue growth: 4.0327973511813555%
Rule of 40 score: -332.72102962184874
Market cap: 24635523072 (Large Cap ($10B-$200B))
P/E ratio: 0.6134874600486879
Debt to equity: 2.4319
Free cash flow (dilution adjusted): -74081273.84484951
Operating income: 3917157.6939381096
Net income: 2995178.041543027
Long score: 1 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for MUFIN.NS (quarterly, report date 2026-03-31)
Altman Z-score: 2.1079738217048742 (Grey Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.059713129161489%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.7171726258999123%
Revenue growth: 10.478968264373371%
Rule of 40 score: 10.478968264373371
Market cap: 24635523072 (Large Cap ($10B-$200B))
P/E ratio: 0.6134874600486879
Debt to equity: 2.4319
Operating income: 1540960.152607037
Net income: 1175000
Long score: 1 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for MUKANDLTD.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.397623046337383 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 37.77864221054506%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.90783712196511%
Revenue growth: -9.317413158858932%
Rule of 40 score: -9.317413158858932
Market cap: 19998185472 (Large Cap ($10B-$200B))
P/E ratio: 0.030196188416342397
Debt to equity: 1.1146
Operating income: -3763247.1386180585
Net income: 58815175.92200085
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for NCI (annual, report date 2025-12-31)
Altman Z-score: 3.161407038328943 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.2209184833987157%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.8903110034492872%
Free cash flow margin: 12.653662266578996%
Revenue growth: -41.91206502966613%
Rule of 40 score: -29.258402763087133
Market cap: 27709034 (Nano Cap (< $50M))
P/E ratio: 112.99999999999999
Debt to equity: 0.8205
Free cash flow (dilution adjusted): 2232238.431876607
Operating income: 232002.44215938303
Net income: 42632.262210796915
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for NCI (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 27709034 (Nano Cap (< $50M))
P/E ratio: 112.99999999999999
Debt to equity: 0.8205
Long score: 1 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for NWBI (quarterly, report date 2026-03-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.403657928757771%
Capitalized R&D asset: 0
Free cash flow margin: 39.537620704304594%
Revenue growth: -2.736658718946657%
Rule of 40 score: 36.80096198535794
Market cap: 2253245696 (Mid Cap ($2B-$10B))
P/E ratio: 13.597826086956522
Debt to equity: 0.3128917763784936
Free cash flow (dilution adjusted): 68869000
Net income: 50536000
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for OBD.L (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5363638 (Nano Cap (< $50M))
Debt to equity: 1.3161
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for OEL.AX (annual, report date 2024-06-30)
Altman Z-score: 0.9588534392087926 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -7.57319759608187%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.8479388272703183%
Free cash flow margin: 24.850455136540962%
Revenue growth: -38.960233395537095%
Rule of 40 score: -14.109778258996133
Market cap: 28770058 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): 3822000
Operating income: -298666.6666666667
Net income: -1102000
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for OMDA (quarterly, report date 2026-03-31)
Altman Z-score: 9.538010974786921 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -0.7035079464420314%
Capitalized R&D asset: 23836170
ROCI (R&D adjusted): -1.3958551887983304%
Rosenberg metric: -0.4301419667590028
Free cash flow margin: -22.55022550225502%
Revenue growth: 2.903251325053398%
Rule of 40 score: -19.646974177201624
Market cap: 1220477952 (Small Cap ($300M-$2B))
Debt to equity: 0
Free cash flow (dilution adjusted): -17600000
Operating income: -4781000
Net income: -2970000
Long score: 4 | Short score: 15
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for PNT.AX (annual, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -15.25443154240177%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -9.82284396509257%
Rule of 40 score: 0
Market cap: 2858609 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -876218.7919463087
Operating income: -611451.0067114094
Net income: -476171.14093959733
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for PNT.AX (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2858609 (Nano Cap (< $50M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for PSON.L (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 7361094144 (Mid Cap ($2B-$10B))
P/E ratio: 0.273449920508744
Debt to equity: 0.40509999999999996
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for REFL.OL (annual, report date 2026-03-31)
Altman Z-score: 576.9460011453608 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 38.50516363405619%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.8732966353094216%
Rule of 40 score: 0
Market cap: 918210432 (Small Cap ($300M-$2B))
P/E ratio: 0.17003204159361585
Debt to equity: 0.0029
Free cash flow (dilution adjusted): 7811494.252873563
Operating income: -1265517.2413793104
Net income: 55798850.57471264
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for REFL.OL (quarterly, report date 2026-03-31)
Altman Z-score: 576.9710702240751 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.0573155448387457%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.10787315386201754%
Rule of 40 score: 0
Market cap: 918210432 (Small Cap ($300M-$2B))
P/E ratio: 0.17003204159361585
Debt to equity: 0.0029
Free cash flow (dilution adjusted): -473563.2183908046
Operating income: -156321.83908045976
Net income: -1532183.9080459771
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for REGENCERAM.NS (quarterly, report date 2026-03-31)
Altman Z-score: -0.0385041595667763 (Distress Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -59.52201117110057%
Revenue growth: -6.993740508503304%
Rule of 40 score: -6.993740508503304
Market cap: 897427392 (Small Cap ($300M-$2B))
Debt to equity: -1.300657145444062
Operating income: -1352946.1636286562
Net income: -1324077.999152183
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for REGENCERAM.NS (annual, report date 2026-03-31)
Altman Z-score: -0.21264743590960838 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -127.33842466966921%
Free cash flow margin: -89.61659672100303%
Revenue growth: 163.8688633595145%
Rule of 40 score: 74.25226663851147
Market cap: 897427392 (Small Cap ($300M-$2B))
Debt to equity: -1.300657145444062
Free cash flow (dilution adjusted): -3634410.767274269
Operating income: -2894425.604069521
Net income: -2527002.9673590506
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for SOAG.OL (quarterly, report date 2026-03-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.5381717231806467%
Capitalized R&D asset: 0
Free cash flow margin: 98.37662337662336%
Revenue growth: 7.114308553157482%
Rule of 40 score: 105.49093192978084
Market cap: 5326735360 (Mid Cap ($2B-$10B))
P/E ratio: 0.9061951743754663
Debt to equity: 0.9803149606299213
Free cash flow (dilution adjusted): 31140801.644398764
Net income: 12949640.287769783
Long score: 3 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for TRP.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 2016437.7402207507
Rule of 40 score: 0
Market cap: 4716258 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for TXG (quarterly, report date 2026-03-31)
Altman Z-score: 16.146795925905906 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -0.4209877810863539%
Capitalized R&D asset: 113220250
ROCI (R&D adjusted): -1.6613464154473998%
Rosenberg metric: -0.12269291929460951
Free cash flow margin: 1.2469919054911398%
Revenue growth: -9.147142082756128%
Rule of 40 score: -7.9001501772649885
Market cap: 5874263040 (Mid Cap ($2B-$10B))
Debt to equity: 0.1
Free cash flow (dilution adjusted): 1881000
Operating income: -17046000
Net income: -13470000
Long score: 8 | Short score: 11
Recommendation: Short
Stock screener scorecard for UGARSUGAR.NS (annual, report date 2026-03-31)
Altman Z-score: 1.4605627255337141 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.817753178235009%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 22.777737271809624%
Free cash flow margin: 1.3324224410968704%
Revenue growth: 1.1800854642704321%
Rule of 40 score: 2.5125079053673023
Market cap: 4468499968 (Mid Cap ($2B-$10B))
P/E ratio: 0.34172219616022487
Debt to equity: 3.1058999999999997
Free cash flow (dilution adjusted): 2095866.8927511657
Operating income: 7449268.757948283
Net income: 1442560.4069520982
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for UGARSUGAR.NS (quarterly, report date 2026-03-31)
Altman Z-score: 0.6071346351496696 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 23.982081478076527%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 19.635349072332318%
Revenue growth: 15.421991475525868%
Rule of 40 score: 15.421991475525868
Market cap: 4468499968 (Mid Cap ($2B-$10B))
P/E ratio: 0.34172219616022487
Debt to equity: 3.1058999999999997
Operating income: 6421576.939381094
Net income: 4849607.8846969055
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for URG (quarterly, report date 2026-03-31)
Altman Z-score: -0.2896244378908317 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -47.087214633910904%
Capitalized R&D asset: 30575890
ROCI (R&D adjusted): -7.157809109792772%
Rosenberg metric: -0.014034223808937584
Free cash flow margin: -748.1811243958281%
Revenue growth: -62.37917504067375%
Rule of 40 score: -810.5602994365019
Market cap: 484744864 (Small Cap ($300M-$2B))
Debt to equity: 1.0445
Free cash flow (dilution adjusted): -29411000
Operating income: -20333000
Net income: -28775000
Long score: 0 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)